307 evolution "https:" "https:" "https:" "https:" "UCL" "UCL" "UCL" positions at Virginia Tech
Sort by
Refine Your Search
-
Category
-
Program
-
Field
-
endorses and encourages participation in professional development opportunities and university shared governance . These valuable contributions to university shared governance provide important
-
in research annually. Virginia Tech endorses and encourages participation in professional development opportunities and university shared governance . These valuable contributions to university shared
-
, Virginia Tech conducts more than $650 million in research annually. Virginia Tech endorses and encourages participation in professional development opportunities and university shared governance
-
leading global research institution, Virginia Tech conducts more than $650 million in research annually. Virginia Tech endorses and encourages participation in professional development opportunities and
-
more than $650 million in research annually. Virginia Tech endorses and encourages participation in professional development opportunities and university shared governance . These valuable contributions
-
participation in professional development opportunities and university shared governance . These valuable contributions to university shared governance provide important representation and perspective, along
-
participation in professional development opportunities and university shared governance . These valuable contributions to university shared governance provide important representation and perspective, along
-
participation in professional development opportunities and university shared governance . These valuable contributions to university shared governance provide important representation and perspective, along
-
development opportunities and university shared governance . These valuable contributions to university shared governance provide important representation and perspective, along with opportunities for unique
-
bone marrow failure and its role in clonal selection 3. Clonal evolution and therapeutic vulnerabilities: using single cell sequencing to track clonal dynamics and to identify targets in high risk MDS